A Randomised, Open Label, Single Centre, 2 Way Crossover Bioequivalence Study Comparing Arimidex Tablet 1 mg and Anastrozole Orally Rapid Disintegration Film Formula 1 mg After Single Oral Administration in Japanese Healthy Male Subjects.

Trial Profile

A Randomised, Open Label, Single Centre, 2 Way Crossover Bioequivalence Study Comparing Arimidex Tablet 1 mg and Anastrozole Orally Rapid Disintegration Film Formula 1 mg After Single Oral Administration in Japanese Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jun 2012

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Breast cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 22 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Jun 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
    • 22 Jun 2012 Actual patient number is 58 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top